INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 99 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $231,000 | +100.9% | 134,457 | +100.8% | 0.02% | +54.5% |
| Q2 2022 | $115,000 | -43.6% | 66,957 | +17.5% | 0.01% | -38.9% |
| Q1 2022 | $204,000 | -20.9% | 57,000 | +10.0% | 0.02% | -14.3% |
| Q4 2021 | $258,000 | +437.5% | 51,800 | +838.9% | 0.02% | +320.0% |
| Q4 2020 | $48,000 | -77.3% | 5,517 | -69.8% | 0.01% | -79.2% |
| Q3 2020 | $211,000 | -10.2% | 18,244 | +109.1% | 0.02% | -22.6% |
| Q2 2020 | $235,000 | +591.2% | 8,723 | +138.9% | 0.03% | +675.0% |
| Q3 2016 | $34,000 | -68.2% | 3,652 | -68.6% | 0.00% | -63.6% |
| Q2 2016 | $107,000 | +5250.0% | 11,617 | +3878.4% | 0.01% | – |
| Q1 2016 | $2,000 | -77.8% | 292 | -78.9% | 0.00% | -100.0% |
| Q4 2015 | $9,000 | +28.6% | 1,381 | +6.2% | 0.00% | +100.0% |
| Q3 2015 | $7,000 | -70.8% | 1,300 | -55.9% | 0.00% | -83.3% |
| Q1 2015 | $24,000 | +84.6% | 2,946 | +96.4% | 0.01% | +50.0% |
| Q4 2014 | $13,000 | -84.1% | 1,500 | -80.3% | 0.00% | -69.2% |
| Q2 2014 | $82,000 | – | 7,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
| Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
| ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
| WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
| Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
| Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
| Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
| BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |